MetLife Investment Management’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$400K Buy
46,692
+15,001
+47% +$106K ﹤0.01% 2050
2026
Q1
$204K Sell
31,691
-7,441
-19% -$57.5K ﹤0.01% 2219
2025
Q4
$320K Buy
39,132
+7,881
+25% +$71.2K ﹤0.01% 2030
2025
Q3
$277K Hold
31,251
﹤0.01% 2129
2025
Q2
$163K Hold
31,251
﹤0.01% 2289
2025
Q1
$169K Buy
31,251
+4,349
+16% +$20.5K ﹤0.01% 2284
2024
Q4
$123K Sell
26,902
-5,615
-17% -$28.8K ﹤0.01% 2528
2024
Q3
$169K Hold
32,517
﹤0.01% 2366
2024
Q2
$89.7K Buy
+32,517
New +$81.1K ﹤0.01% 2653
2022
Q2
Sell
-28,914
Closed -$98.6K 2865
2022
Q1
$98.6K Buy
28,914
+10,246
+55% +$55.6K ﹤0.01% 2627
2021
Q4
$138K Buy
18,668
+11,021
+144% +$80.1K ﹤0.01% 2281
2021
Q3
$61.3K Sell
7,647
-9,406
-55% -$91.2K ﹤0.01% 2518
2021
Q2
$211K Buy
+17,053
New +$202K ﹤0.01% 2137

Other funds holding AVAH

MetLife Investment Management's AVAH Position: Q2 2026 in Review

MetLife Investment Management increased its Aveanna Healthcare (AVAH) stake by 47% in Q2 2026, buying an estimated $106K and bringing the position to 46,692 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2050.

MetLife Investment Management first reported a position in AVAH in Q2 2021 and has held it in 13 quarters since. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • MetLife Investment Management held 46,692 shares of Aveanna Healthcare worth $400K as of Q2 2026.
  • MetLife Investment Management bought 15,001 Aveanna Healthcare shares in Q2 2026, an estimated $106K.
  • Aveanna Healthcare made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2050 holding.
  • MetLife Investment Management first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 13 quarters since.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.